Patents by Inventor Angelica A. Cornelison

Angelica A. Cornelison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
    Publication number: 20220356249
    Abstract: Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
    Type: Application
    Filed: July 19, 2022
    Publication date: November 10, 2022
    Inventors: Ernest S. SMITH, Angelica CORNELISON, Maria SCRIVENS, Mark PARIS, Maurice ZAUDERER
  • Human anti-semaphorin 4D antibody
    Patent number: 11427634
    Abstract: Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: August 30, 2022
    Assignee: Vaccinex, Inc.
    Inventors: Ernest S. Smith, Angelica Cornelison, Maria G. M. Scrivens, Mark Paris, Maurice Zauderer
  • HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
    Publication number: 20210032329
    Abstract: Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
    Type: Application
    Filed: May 4, 2018
    Publication date: February 4, 2021
    Inventors: Ernest S. SMITH, Angelica CORNELISON, Maria G.M. SCRIVENS, Mark PARIS, Maurice ZAUDERER
  • Integral membrane protein display on poxvirus extracellular enveloped virions
    Patent number: 10870707
    Abstract: This disclosure provides compositions and methods for expressing and displaying isolated integral membrane proteins (IMPs) or fragments thereof in a native conformation for use in the screening, selecting, and identifying of antibodies or antibody-like molecules that bind to a target IMP of interest.
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: December 22, 2020
    Assignee: Vaccinex, Inc.
    Inventors: Ernest S. Smith, Mark Paris, Maria G. M. Scrivens, Renee A. Kirk, Angelica A. Cornelison
  • INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
    Publication number: 20200216562
    Abstract: This disclosure provides compositions and methods for expressing and displaying isolated integral membrane proteins (IMPs) or fragments thereof in a native conformation for use in the screening, selecting, and identifying of antibodies or antibody-like molecules that bind to a target IMP of interest.
    Type: Application
    Filed: December 26, 2019
    Publication date: July 9, 2020
    Inventors: Ernest S. Smith, Mark Paris, Maria G.M. Scrivens, Renee A. Kirk, Angelica A. Cornelison
  • Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit
    Patent number: 10662422
    Abstract: The present invention relates to a high efficiency method of expressing immunoglobulin molecules in eukaryotic cells. The invention is further drawn to a method of producing immunoglobulin heavy and light chain libraries, particularly using the trimolecular recombination method, for expression in eukaryotic cells. The invention further provides methods of selecting and screening for antigen-specific immunoglobulin molecules, and antigen-specific fragments thereof. The invention also provides kits for producing, screening and selecting antigen-specific immunoglobulin molecules. Finally, the invention provides immunoglobulin molecules, and antigen-specific fragments thereof, produced by the methods provided herein.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: May 26, 2020
    Assignee: Vaccinex, Inc.
    Inventors: Ernest S. Smith, Tracy Pandina, Leslie A. Balch, Mark Paris, Maurice Zauderer, Angelica Cornelison, Renee Kirk
  • Integral membrane protein display on poxvirus extracellular enveloped virions
    Patent number: 10577427
    Abstract: This disclosure provides compositions and methods for expressing and displaying isolated integral membrane proteins (IMPs) or fragments thereof in a native conformation for use in the screening, selecting, and identifying of antibodies or antibody-like molecules that bind to a target IMP of interest.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: March 3, 2020
    Assignee: Vaccinex, Inc.
    Inventors: Ernest S. Smith, Mark Paris, Maria G. M. Scrivens, Renee A. Kirk, Angelica A. Cornelison
  • Integral membrane protein display on poxvirus extracellular enveloped virions
    Patent number: 10550199
    Abstract: This disclosure provides compositions and methods for expressing and displaying isolated integral membrane proteins (IMPs) or fragments thereof in a native conformation for use in the screening, selecting, and identifying of antibodies or antibody-like molecules that bind to a target IMP of interest.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: February 4, 2020
    Assignee: Vaccinex, Inc.
    Inventors: Ernest S. Smith, Mark Paris, Maria G. M. Scrivens, Renee A. Kirk, Angelica A. Cornelison
  • INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
    Publication number: 20190276556
    Abstract: This disclosure provides compositions and methods for expressing and displaying isolated integral membrane proteins (IMPs) or fragments thereof in a native conformation for use in the screening, selecting, and identifying of antibodies or antibody-like molecules that bind to a target IMP of interest.
    Type: Application
    Filed: April 15, 2019
    Publication date: September 12, 2019
    Inventors: Ernest S. Smith, Mark Paris, Maria G.M. Scrivens, Renee A. Kirk, Angelica A. Cornelison
  • INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
    Publication number: 20190112388
    Abstract: This disclosure provides compositions and methods for expressing and displaying isolated integral membrane proteins (IMPs) or fragments thereof in a native conformation for use in the screening, selecting, and identifying of antibodies or antibody-like molecules that bind to a target IMP of interest.
    Type: Application
    Filed: April 21, 2017
    Publication date: April 18, 2019
    Applicant: Vaccinex, Inc.
    Inventors: Ernest S. Smith, Mark Paris, Maria G.M. Scrivens, Renee A. Kirk, Angelica A. Cornelison